quinazolines has been researched along with ly335979 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuchs, H; Held, HD; Runge, F | 1 |
Alcantara, LM; Ayong, LS; Franco, CH; Franzoi, KD; Freitas-Junior, LH; Kim, J; Lee, S; Moraes, CB | 1 |
2 other study(ies) available for quinazolines and ly335979
Article | Year |
---|---|
Excretion of the dipeptidyl peptidase-4 inhibitor linagliptin in rats is primarily by biliary excretion and P-gp-mediated efflux.
Topics: Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile; Biliary Tract; Biological Availability; Biological Transport; Diabetes Mellitus, Type 2; Dibenzocycloheptenes; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Intestinal Mucosa; Linagliptin; Male; Purines; Quinazolines; Quinolines; Rats; Rats, Wistar | 2012 |
Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites.
Topics: Antimalarials; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Boron Compounds; Chloroquine; Chlorpheniramine; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Erythrocytes; Fluorescent Dyes; Gefitinib; Humans; Imatinib Mesylate; Mefloquine; Piperazines; Plasmodium falciparum; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Quinolines | 2013 |